215 embedded-system "https:" "https:" "https:" "https:" "UCL" positions at ETH Zurich
Sort by
Refine Your Search
-
portal. Applications via email or postal services will not be considered. Candidates will be informed if their proposal is accepted for furhter consideration in January 2026. For information about the gta
-
intelligence and decision support for large fleets of civil infrastructure assets, including bridges, railways, and wind turbines. Project background The scientific aim of DIAMOND is to develop decentralized
-
group. She will study epigenomic signatures associated with high-altitude adaptation in the alpine plant Arabis alpina, and is looking for a motivated PhD student to join her team. Project background High
-
) motivation letter at least 2 names of referees (with email addresses and phone numbers) Please note that the review of applications will begin on December 1, 2025 and continue until the position is filled
-
2026, with a 100% workload, based in Zurich, and is fixed-term for three and a half years. Working across sociocultural, political-economic, and theoretical contexts, the LUS Doctoral Program fosters
-
. Space is a major economic growth area, and strengthening the Swiss space ecosystem has been defined as a strategic priority of ETH Zurich. Particularly in terms of space spin-offs/start-ups ETH Zurich
-
100%, Zurich, fixed-term The bioMatter Microfluidics Group of Dr Eleonora Secchi at ETH Zurich is seeking two PhD candidates. Our research focuses on uncovering the physicochemical mechanisms
-
systems (wastewater treatment plants) and natural aquatic and terrestrial environments. Key processes governing the transport and (bio)availability of these polymers—such as their adsorption to solid–water
-
email, postal services, or social networks will not be considered. We would like to point out that the pre-selection is carried out by the responsible recruiters and not by artificial intelligence. ETH
-
biomaterials for sealing, healing, and integration with human tissue. Veltist is a pioneering MedTech spin-off from the ETH Domain (ETH Zurich and Empa), currently part of the Wyss Zurich Translational Center’s